Estimates of the burden of Group B Streptococcal disease worldwide for pregnant women, stillbirths, and children
-
31/10/2017
-
Clinical Infectious Diseases
The researchers aimed to provide the first comprehensive estimates of the burden of group B Streptococcus (GBS), including invasive disease in pregnant and postpartum women, fetal infection/stillbirth, and infants. Intrapartum antibiotic prophylaxis is the current mainstay of prevention, reducing early-onset infant disease in high-income contexts. Maternal GBS vaccines are in development.